Scientists probe genetic link in HIV drug Mix-Ups
NCT ID NCT05789173
Summary
This study aims to understand how a key HIV medication (efavirenz) interacts with two other drugs (methadone and tizanidine) and whether a person's genetics affects these interactions. Researchers will enroll 60 healthy volunteers, grouped by their genetic makeup, to measure drug levels and effects in the body before and after taking efavirenz. The goal is to learn how to better predict and avoid harmful drug interactions or reduced effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana University School of Medicine
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.